跳至主要内容
临床试验/ITMCTR2200006151
ITMCTR2200006151尚未招募未知

Huoxiang anwei Capsule for the treatment of Helicobacter pylori infection in a randomized controlled clinical study

Spleen and Stomach Department, Shenzhen Hospital of Traditional Chinese Medicine, No. 1 fuhua Road, Futian District, Shenzhen city0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) Meet the diagnostic criteria for Hp infection;
  • (2) 18-65 years old;
  • (3) Voluntarily accept the experiment and sign the informed consent.

排除标准

  • (1) Patients with serious lesions of heart, liver and kidney, hematopoietic system diseases and tumors;
  • (2) Antibiotics, acid suppressants and bismuth were used within 4 weeks before treatment;
  • (3) Systemic diseases that affect the motility of the digestive tract (e.g., hyperthyroidism, diabetes, chronic renal insufficiency, mental and neurological disorders)
  • Pathological changes, etc.);
  • (4) those with a history of abdominal surgery (except appendectomy and cesarean section);
  • (5) pregnant or planning to be pregnant, breast-feeding women;
  • (6) Those who have a history of drug allergy or severe food allergy used in the study;
  • Project Name: Huoxiang Anwei Capsule in the treatment of Helicobacter pylori infection randomized controlled clinical study Version no. : Version 1.0 Date: 20220330
  • (7) have a history of neurological and mental diseases;
  • (8) Subjects who are participating in other clinical trials.

研究者

发起方
Spleen and Stomach Department, Shenzhen Hospital of Traditional Chinese Medicine, No. 1 fuhua Road, Futian District, Shenzhen city

相似试验